TY  - RPRT
TI  - Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates
AU  - Fisher, J. L.
AU  - Wilk, E. J.
AU  - Oza, V. H.
AU  - Howton, T. C.
AU  - Flanary, V. L.
AU  - Clark, A. D.
AU  - Hjelmeland, A. B.
AU  - Lasseigne, B. N.
PY  - 2023
DO  - 10.1101/2023.03.10.532074
UR  - https://www.biorxiv.org/content/10.1101/2023.03.10.532074v1
ID  - 10.1101/2023.03.10.532074
ER  -